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Hypothesis
HEK293-hFSHR cells that are treated with the wild-type (interfering) peptide 
will express decreased levels of cAMP. There should be no difference in the 
level of cAMP in the cells treated with the mutant peptide and the cells 
treated with no peptide. 
Follicle Stimulating Hormone Receptor and Caveolin
Prepare 96 well dish of hFSHR-EPAC 
cells.
Pretreatment
Aspirate wells and wash with S/F 
medium
Introduce WT and MU peptides into 
cells
Incubate 1 hour 
Remove medium and wash with 1X PBS
and take baseline reading 
Treatment & Analyze
Treat with 1x PBS with IBMX, forskolin, 
FSH
Take kinetic read for 15 minutes 
Take final read 
Current FSHR signaling pathway model & cAMP detection
● FSHR is a G-Protein Coupled Receptor (GPCR) activated by FSH
● Located in the membranes of Sertoli Cells in testes and granulosa 
cells in ovaries
● FSH aids in follicle maturation and estrogen production in women 
and sperm development in men
● The protein caveolin is thought to interact with transmembrane 
domain IV (circled) to promote the binding of the receptor to the 
caveolae, a type of lipid raft
● Lipid rafts support a diverse group of receptors that are needed at 
the cell membrane
1a. When FSH binds to FSHR 
the G protein alpha subunit 
activates adenylyl cyclase 
to stimulate production of 
cAMP
1b. FSH activates downstream 
phosphorylation of p44 
MAP Kinase
2.   cAMP activates protein 
kinase A
3.   Protein kinase A activates 
the MAP kinases and the 
cAMP response element 
binding protein (CREB)
Introduction
● In the presence of the wild type (blocking) peptide, there is an 
increase in basal levels of cAMP, which does not support the 
original hypothesis. This may suggest that caveolin plays a role 
in turning the hFSH receptor off. 
● This observation is consistent with the western blot analysis 
from the Cohen lab, but inconsistent with known literature that 
suggests caveolin blocking peptides have a diminished capacity 
to stimulate the receptor (Roh et al, 2014).
● Although it is unclear what role the mutant (non-blocking) 
peptide may be playing, our data suggests that the tat mutant 
peptide sequence may not be the best control. 
● In the future, this experiment should be repeated using a mutant 
peptide with a scrambled caveolin binding motif sequence. 
Western Blot analysis of p44 levels in response to hFSH treatment for different times 
following pretreatment with WT and MU peptide mimetics of the hFHSR-caveolin 
interaction motif. 
Western blot analysis of p-CREB levels in response to hFSH treatment following 
pretreatment with different doses of peptide mimetics of the hFSHR-caveolin 
interaction motif. 
●EPAC serves as a highly sensitive 
CAMP indicator. When expressed in 
mammalian cells, EPAC shows 
significant FRET. 
●Fluorescence resonance transfer 
energy (FRET) is expressed as a ratio 
of CFP to YFP. 
●FRET decreases in response to CAMP 
production and fully recovers in the 
presence of CAMP lowering agonists.
●No cAMP = Emission at 530 nm
●CAMP = Emission changes to 480nm
● CREB and p44 pathways measure hFSHR response indirectly. This 
experiment attempts to measure hFSHR activation more directly through 
monitoring cAMP production
Tat -WT Caveolin binding motif peptide ygrkkrrqrrrFAFAAALFPIF
Tat -Mutant Caveolin binding motif peptide ygrkkrrqrrrLALAAALLPIL
Wild type and mutant caveolin binding motifs. The Tat peptide is in small letters and the 
hFSHR caveolin binding motif is in capital letters.  Mutated residues are in bold.
This figure compares the ratio of LM1 (480nm, no FRET) to LM2 
(530nm, FRET) at t=0 to the ratio of LM1 to LM2 at t = 5 minutes. The 
difference in cAMP levels between t=0 and t=5 in each well were then 
averaged. 
This figure compares the ratio of LM1 (480nm, no FRET) to LM2 
(530nm, FRET) at t=0 to the ratio of LM1 to LM2 at t = 15 minutes. The 
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